Search by Drug Name or NDC

    NDC 59651-0269-30 Glipizide 5 mg/1 Details

    Glipizide 5 mg/1

    Glipizide is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is GLIPIZIDE.

    Product Information

    NDC 59651-0269
    Product ID 59651-269_46e7be05-f8c9-4a43-bafe-3dc5271c0b9c
    Associated GPIs 27200030007510
    GCN Sequence Number 021840
    GCN Sequence Number Description glipizide TAB ER 24 5 MG ORAL
    HIC3 C4K
    HIC3 Description ANTIHYPERGLYCEMIC, INSULIN-RELEASE STIMULANT TYPE
    GCN 10844
    HICL Sequence Number 000803
    HICL Sequence Number Description GLIPIZIDE
    Brand/Generic Generic
    Proprietary Name Glipizide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Glipizide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units mg/1
    Substance Name GLIPIZIDE
    Labeler Name Aurobindo Pharma Limited
    Pharmaceutical Class Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA206928
    Listing Certified Through n/a

    Package

    NDC 59651-0269-30 (59651026930)

    NDC Package Code 59651-269-30
    Billing NDC 59651026930
    Package 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-269-30)
    Marketing Start Date 2017-05-12
    NDC Exclude Flag N
    Pricing Information N/A